Considering metformin in cardiometabolic protection in psychosis

Acta Psychiatr Scand. 2012 Oct;126(4):302-3. doi: 10.1111/j.1600-0447.2012.01906.x. Epub 2012 Jul 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / adverse effects
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Metformin / therapeutic use*
  • Obesity / prevention & control
  • Psychotic Disorders / complications*
  • Weight Gain

Substances

  • Antipsychotic Agents
  • Hypoglycemic Agents
  • Metformin